Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06719180 · ClinicalTrials.gov registry record · Phase 4
Vaginal Cuff Anesthesia and Post-Operative Pain Medication Use
A Phase 4 study of Hysterectomy and Post Operative Analgesia, sponsored by MediSys Health Network.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06719180 is a Phase 4 study of Hysterectomy and Post Operative Analgesia that is actively recruiting participants, run by MediSys Health Network. The registered enrollment target is 100 participants, below the 127-participant average among 8 other Hysterectomy trials with a reported enrollment target (21% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06719180, a Phase 4 study of Hysterectomy and Post Operative Analgesia, is actively recruiting participants, sponsored by MediSys Health Network.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether an injection of a local anesthetic (Bupivacaine with epinephrine) in the vaginal cuff prior to closure would result in less immediate postoperative pain medication and increase patient comfort/satisfaction.
Conditions Studied
Interventions
- DRUG Bupivacain
- OTHER Saline (NaCl 0,9 %) (placebo)
Study Locations (1)
New York
- Flushing Hospital Medical Center - Flushing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-12-01 |
| Est. Completion | 2025-10-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06719180
The ClinicalTrials.gov registry entry for NCT06719180 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 127-participant average among 8 other Hysterectomy trials with a reported enrollment target (21% lower). The listed sponsor is MediSys Health Network, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hysterectomy appearing as the primary indexed condition, and to 2 interventions - of which Bupivacain is the first listed.
NCT06719180 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06719180 about?
NCT06719180 is a clinical study titled "Vaginal Cuff Anesthesia and Post-Operative Pain Medication Use". The purpose of this study is to determine whether an injection of a local anesthetic (Bupivacaine with epinephrine) in the vaginal cuff prior to closure would result in less immediate postoperative pain medication and increase patient comfort/satisfaction.
What is the current status of trial NCT06719180?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2024-12-01. Estimated completion is 2025-10-31.
What conditions does trial NCT06719180 study?
This clinical trial studies the following conditions: Hysterectomy, Post Operative Analgesia.
What interventions are being tested in trial NCT06719180?
The interventions under investigation include: Bupivacain (DRUG), Saline (NaCl 0,9 %) (placebo) (OTHER).
Who is sponsoring clinical trial NCT06719180?
This trial is sponsored by MediSys Health Network, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06719180 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hysterectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mixture of Liposomal Bupivacaine and Bupivacaine for TAP Block for Open Hysterectomy
COMPLETED · Phase 4
-
NAC vs Placebo on Opioid Use for Hysterectomy
RECRUITING · Phase 3
-
Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy
RECRUITING · Phase 3
-
Bilateral Oophorectomy Versus Ovarian Conservation
COMPLETED · NA
-
Ultravision Visual Clearing System in Laparoscopic Hysterectomy and Myomectomy
COMPLETED · NA
-
Urinary Tract Infections Rates Using 50% Dextrose Plus Washout Versus Normal Saline as Cystoscopy Fluid
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.